本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

20.91
-0.7200-3.33%
盘后21.320.4100+1.96%19:57 EDT
成交量:161.87万
成交额:3,397.70万
市值:25.07亿
市盈率:-28.15
高:21.84
开:21.75
低:20.34
收:21.63
52周最高:21.84
52周最低:8.03
股本:1.20亿
流通股本:8,558.07万
量比:0.95
换手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-0.7427
每股收益(LYR):-1.1578
净资产收益率:-57.33%
总资产收益率:-13.46%
市净率:18.04
市盈率(LYR):-18.06

数据加载中...

2025/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities